Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
· Financial Post
VANCOUVER, BC and BOSTON, MA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the company will present at an upcoming investor conference: Read More
Visit fishroad-app.com for more information.